Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Obesity, Morbid × Leuprolide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 80 Breast Neoplasms 14 Neoplasms 5 Salivary Gland Neoplasms 2 Prostate Adenocarcinoma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leiomyoma 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urogenital Neoplasms 1 Skin Neoplasms 1 Skin Diseases 1 Salivary Gland Neoplasm Duct 1 Recurrence 1 Rare Diseases 1 Prostatic Diseases 1 Polycystic Ovary Syndrome 1 PSA Level Greater Than Two 1 Obesity, Morbid 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasms, Glandular and Epithelial 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Melanoma 1 Lymphatic Metastasis 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hormone Sensitive Prostate Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04331717 2022-05-02

BASH-PC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Obesity, Morbid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡